Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Katharina Inholz1,2, Janet L Anderl3, Moritz Klawitter2

  • 1Biotechnology Institute Thurgau (BITg) at the University of Konstanz, Kreuzlingen, Switzerland.

European Journal of Immunology
|March 8, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PLGA-particle-based vaccine induces SARS-CoV-2-specific antibody and T-cell responses.

British journal of pharmacology·2026
Same author

Vimentin 3 expression in odontogenic keratocysts - a molecular and immunohistochemical study.

Polish journal of pathology : official journal of the Polish Society of Pathologists·2026
Same author

Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active Sites.

Journal of medicinal chemistry·2026
Same author

Immunoproteasome inhibition triggers protein stress and apoptosis in cells of B cell lineage without impairing vaccination-induced antibody responses.

Cell death discovery·2025
Same author

Inhibitors of the 20S proteasome β5 subunit as potent and selective agents against <i>Trichomonas vaginalis</i>.

Antimicrobial agents and chemotherapy·2025
Same author

Preclinical characterization of novel multi-client inhibitors of Sec61 with broad antitumor activity.

The Journal of pharmacology and experimental therapeutics·2025

Most immune cells primarily use immunoproteasomes, not standard proteasomes. This study quantifies these proteasome subunits across various mouse and human immune cell types, revealing their constitutive expression and suggesting a key role for immunoproteasomes in immune function.

Area of Science:

  • Immunology
  • Cell Biology
  • Proteasome Biology

Context:

  • Immunoproteasomes are induced by IFN-γ in inflammation.
  • Certain immune cells constitutively express high levels of immunoproteasomes.
  • Basal expression of active immunoproteasome subunits in immune cells is poorly understood.

Purpose:

  • Quantify standard proteasome subunits (β1c, β2c, β5c) and immunoproteasome subunits (LMP2, MECL-1, LMP7).
  • Analyze expression in major murine and human immune cell subsets.
  • Establish a reference for immunoproteasome expression in immune cells.

Summary:

  • Measured proteasome subunit composition in murine (T cells, B cells, dendritic cells, NK cells, neutrophils) and human (T cells, B cells, myeloid dendritic cells, NK cells, granulocytes) immune cells.
Keywords:
ExpressionImmune cellsImmunoproteasomeLymphoid tissueProteasome

Related Experiment Videos

  • Found that proteasomes in most immune cell subsets predominantly comprise immunoproteasome subunits.
  • Data highlights constitutive expression of immunoproteasomes in various immune cell types.

    • Impact:

    • Provides a comprehensive reference for immunoproteasome expression across diverse immune cells.
    • Suggests a specialized and significant role for immunoproteasomes in immune cell function.
    • Informs future research on immunoproteasome function in immunity and inflammation.